<title:>The Daily Startup: Wall Street Unease Dragging Startups Down
<Date:>11 April 2014
<Content:>
Two biotech companies had rocky entries to the public markets Thursday, deepening an IPO slump for venture-backed companies. Cancer drug developer Cerulean Pharma dropped from its opening price of $7 to $6.85, after previously estimating it ...
